Headquartered in Edmonton, AB Fiscal year ends March NASDAQ: ACB auroramj.com
Aurora Cannabis Inc. is a global medical cannabis company that cultivates, manufactures, and distributes cannabis products to medical markets across Canada, Europe, Australia, and New Zealand. The company operates GMP-certified manufacturing facilities in Canada and Germany and has recently expanded its EU-GMP capacity through the acquisition of Safari Flower Company. Aurora's portfolio includes brands such as Aurora, MedReleaf, Pedanios, IndiMed, San Raf, and Whistler Medical Marijuana Corporation. The company is in the process of winding down its consumer cannabis business to focus exclusively on higher-margin global medical cannabis operations. Aurora trades on both the NASDAQ and TSX under the symbol ACB and maintains a debt-free balance sheet. Updated
A Q1 FY2027 revenue record from Tilray Brands (NASDAQ:TLRY) is drawing heavy selling, because the segment that built the company’s following moved the wrong way. Tilray Brands shares are at $3.56, down…
Tilray surged Wednesday alongside Canopy Growth and Aurora Cannabis, but one number from 2026 tells a very different story about why today's rally leaves the real problem untouched.
Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news that the Justice Dept. would reclassify marijuana from Schedule I to Schedule…
Shares of Tilray Brands (NASDAQ:TLRY) are up roughly 10% in early Thursday trading, changing hands near $8.68 after the stock closed up 14% at $7.87 on Wednesday. The catalyst is growing speculation…
The U.S. marijuana industry has stagnated for year, languishing under federal inaction on reclassification or decriminalization. Classified as a Schedule I drug under the Controlled Substances Act — alongside hard drugs like…
It wasn’t that long ago that cannabis stocks promised explosive growth after Canada legalized recreational marijuana in 2018 and U.S. states accelerated reforms. Investors poured billions into the sector, envisioning a booming…
From Hype to Hiccups in the Cannabis Craze Once hailed as the “next big thing,” cannabis stocks in 2018-2019 were the artificial intelligence stock darlings of their day, riding a wave of…
The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug.
Thursday's top analyst upgrades and downgrades included ADT, Aurora Cannabis, CarMax, Shift4 Payments, Skechers USA, Tesla and Tilray.
After U.S. markets close Thursday, Aurora Cannabis and Toast will report quarterly results. Here's what to look for.
President Biden on Thursday pardoned people who had been convicted of federal charges of simple possession of marijuana, sending pot stocks soaring. But strong headwinds remain for the industry.
Wednesday's additional top analyst upgrades and downgrades were on Aurora Cannabis, Block, Cisco Systems, Datadog, Micron Technology, Stitch Fix and more.
Here is what analysts expect when these three companies post their quarterly results late Tuesday or first thing Wednesday morning.
Friday's additional top analyst upgrades and downgrades included Altria, Aurora Cannabis, Baxter International, Marathon Oil, Progressive and Shopify.
Monday’s additional top analyst upgrades and downgrades were on American Express, Aurora Cannabis, Edison International, Eli Lilly, PayPal, Upwork and more.
Aurora Cannabis Inc. is a global medical cannabis company that cultivates, manufactures, and distributes cannabis products to medical markets across Canada, Europe, Australia, and New Zealand.
The Wall Street consensus 12-month price target for ACB is $6.23.
